Irsogladine helps limit chemotherapy-induced oral mucositis
Irsogladine maleate is a promising drug for the management of oral mucositis in patients undergoing 5-fluorouracil-based chemotherapy, results of a randomized placebo-controlled trial indicate.
Source: MedWire News - Oncology - Category: Cancer & Oncology Source Type: news
More News: Cancer & Oncology | Chemotherapy